PRKDC and neoplasm: Using our mouse model designed to delete DNA-PKcs expression in mature CD4<sup>+</sup> or CD8<sup>+</sup> T cells, we show that loss of DNA-PKcs results in T cells that are unable to control tumor growth or induce allogeneic graft rejection.